<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33277362</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>296</Volume><PubDate><Year>2021</Year><Season>Jan-Jun</Season></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Global proteomics of Ubqln2-based murine models of ALS.</ArticleTitle><Pagination><StartPage>100153</StartPage><MedlinePgn>100153</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100153</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA120.015960</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(20)00146-5</ELocationID><Abstract><AbstractText>Familial neurodegenerative diseases commonly involve mutations that result in either aberrant proteins or dysfunctional components of the proteolytic machinery that act on aberrant proteins. UBQLN2 is a ubiquitin receptor of the UBL/UBA family that binds the proteasome through its ubiquitin-like domain and is thought to deliver ubiquitinated proteins to proteasomes for degradation. UBQLN2 mutations result in familial amyotrophic lateral sclerosis (ALS)/frontotemporal dementia in humans through an unknown mechanism. Quantitative multiplexed proteomics was used to provide for the first time an unbiased and global analysis of the role of Ubqln2 in controlling the composition of the proteome. We studied several murine models of Ubqln2-linked ALS and also generated Ubqln2 null mutant mice. We identified impacts of Ubqln2 on diverse physiological pathways, most notably serotonergic signaling. Interestingly, we observed an upregulation of proteasome subunits, suggesting a compensatory response to diminished proteasome output. Among the specific proteins whose abundance is linked to UBQLN2 function, the strongest hits were the ubiquitin ligase TRIM32 and two retroelement-derived proteins, PEG10 and CXX1B. Cycloheximide chase studies using induced human neurons and HEK293&#xa0;cells suggested that PEG10 and TRIM32 are direct clients. Although UBQLN2 directs the degradation of multiple proteins via the proteasome, it surprisingly conferred strong protection from degradation on the Gag-like protein CXX1B, which is expressed from the same family of retroelement genes as PEG10. In summary, this study charts the proteomic landscape of ALS-related Ubqln2 mutants and identifies candidate client proteins that are altered in&#xa0;vivo in disease models and whose degradation is promoted by UBQLN2.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Whiteley</LastName><ForeName>Alexandra M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prado</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Poot</LastName><ForeName>Stefanie A H</ForeName><Initials>SAH</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paulo</LastName><ForeName>Joao A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashton</LastName><ForeName>Marissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dominguez</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Genentech Inc, South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Genentech Inc, South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngu</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathology, Genentech Inc, South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szpyt</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jedrychowski</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Easton</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Genentech Inc, South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gygi</LastName><ForeName>Steven P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Thimo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Henry Wellcome Lab of Cell Biology, College of Medical, Veterinary and Life Sciences, Institute of Molecular, Cell and Systems Biology, University of Glasgow, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>Mervyn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland Medical School, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Immunology and Infectious Diseases, Genentech Inc, South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finley</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: Daniel_finley@hms.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM043601</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM067945</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM132129</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS100008</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS098243</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051017">Apoptosis Regulatory Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C501971">Cxxc1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C110780">Peg10 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405662">UBQLN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C538988">UBQLN2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>333DO1RDJY</RegistryNumber><NameOfSubstance UI="D012701">Serotonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>98600C0908</RegistryNumber><NameOfSubstance UI="D003513">Cycloheximide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C514011">TRIM32 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051017" MajorTopicYN="N">Apoptosis Regulatory Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003513" MajorTopicYN="N">Cycloheximide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055550" MajorTopicYN="N">Protein Stability</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012701" MajorTopicYN="N">Serotonin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">UBQLN2</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">proteasome</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword><Keyword MajorTopicYN="N">ubiquitin</Keyword><Keyword MajorTopicYN="N">ubiquitin ligase</Keyword></KeywordList><CoiStatement>Conflict of interest S. D., M. W., H. N., A. E., and E. J. B. are current employees of Genentech, Inc. A. M. W. is a former employee of Genentech, Inc. D. F. is a consultant for Genentech, Inc. All the other authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>5</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33277362</ArticleId><ArticleId IdType="pmc">PMC7873701</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA120.015960</ArticleId><ArticleId IdType="pii">S0021-9258(20)00146-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blokhuis A.M., Groen E.J., Koppers M., van den Berg L.H., Pasterkamp R.J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004;10 Suppl:S10&#x2013;S17.</Citation><ArticleIdList><ArticleId IdType="pubmed">15272267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood J.D., Beaujeux T.P., Shaw P.J. Protein aggregation in motor neurone disorders. Neuropathol. Appl. Neurobiol. 2003;29:529&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pubmed">14636160</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., Donkervoort S., Ajroud-Driss S., Sufit R.L., Heller S.L., Deng H.X. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011;68:1440&#x2013;1446.</Citation><ArticleIdList><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Ebelle D.L., Wright B.J., Sridharan V., Hooper E., Walters K.J. Structure of hRpn10 bound to UBQLN2 UBL illustrates basis for complementarity between shuttle factors and substrates at the proteasome. J.&#xa0;Mol. Biol. 2019;431:939&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389388</ArticleId><ArticleId IdType="pubmed">30664872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen M.F., Alarcon R.M., Howley P.M. The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. Mol. Biol. Cell. 2003;14:3868&#x2013;3875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC196580</ArticleId><ArticleId IdType="pubmed">12972570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen M.F., Shih A.H., Zhou P., Kumar S., Soccio R.E., Kedersha N.L., Gill G., Howley P.M. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol. Cell. 2000;6:409&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">10983987</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Raasi S., Fushman D. Affinity makes the difference: nonselective interaction of the UBA domain of Ubiquilin-1 with monomeric ubiquitin and polyubiquitin chains. J.&#xa0;Mol. Biol. 2008;377:162&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2323583</ArticleId><ArticleId IdType="pubmed">18241885</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggins S., Ivanovska I., Rose M.D. Yeast ubiquitin-like genes are involved in duplication of the microtubule organizing center. J.&#xa0;Cell Biol. 1996;133:1331&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120900</ArticleId><ArticleId IdType="pubmed">8682868</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsasser S., Finley D. Delivery of ubiquitinated substrates to protein-unfolding machines. Nat. Cell Biol. 2005;7:742&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pubmed">16056265</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., van Dyk D., Li Y., Andrews B., Rao H. A&#xa0;genome-wide synthetic dosage lethality screen reveals multiple pathways that require the functioning of ubiquitin-binding proteins Rad23 and Dsk2. BMC Biol. 2009;7:75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2777868</ArticleId><ArticleId IdType="pubmed">19909498</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicherla B., Kostova Z., Schaefer A., Wolf D.H. A&#xa0;genomic screen identifies Dsk2p and Rad23p as essential components of ER-associated degradation. EMBO Rep. 2004;5:692&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1299090</ArticleId><ArticleId IdType="pubmed">15167887</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsasser S., Gali R.R., Schwickart M., Larsen C.N., Leggett D.S., Muller B., Feng M.T., Tubing F., Dittmar G.A., Finley D. Proteasome subunit Rpn1 binds ubiquitin-like protein domains. Nat. Cell Biol. 2002;4:725&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">12198498</ArticleId></ArticleIdList></Reference><Reference><Citation>Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 2009;78:477&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3431160</ArticleId><ArticleId IdType="pubmed">19489727</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters K.J., Kleijnen M.F., Goh A.M., Wagner G., Howley P.M. Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. Biochemistry. 2002;41:1767&#x2013;1777.</Citation><ArticleIdList><ArticleId IdType="pubmed">11827521</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Chen X., Elsasser S., Stocks B.B., Tian G., Lee B.H., Shi Y., Zhang N., de Poot S.A., Tuebing F., Sun S., Vannoy J., Tarasov S.G., Engen J.R., Finley D. Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome. Science. 2016;351</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4980823</ArticleId><ArticleId IdType="pubmed">26912900</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Randles L., Shi K., Tarasov S.G., Aihara H., Walters K.J. Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 reveal distinct binding mechanisms between substrate receptors and shuttle factors of the proteasome. Structure. 2016;24:1257&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972676</ArticleId><ArticleId IdType="pubmed">27396824</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao H., Sastry A. Recognition of specific ubiquitin conjugates is important for the proteolytic functions of the ubiquitin-associated domain proteins Dsk2 and Rad23. J.&#xa0;Biol. Chem. 2002;277:11691&#x2013;11695.</Citation><ArticleIdList><ArticleId IdType="pubmed">11805121</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeki Y., Saitoh A., Toh-e A., Yokosawa H. Ubiquitin-like proteins and Rpn10 play cooperative roles in ubiquitin-dependent proteolysis. Biochem. Biophys. Res. Commun. 2002;293:986&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pubmed">12051757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson C.R., Seeger M., Hartmann-Petersen R., Stone M., Wallace M., Semple C., Gordon C. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat. Cell Biol. 2001;3:939&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pubmed">11584278</ArticleId></ArticleIdList></Reference><Reference><Citation>Funakoshi M., Sasaki T., Nishimoto T., Kobayashi H. Budding yeast Dsk2p is a polyubiquitin-binding protein that can interact with the proteasome. Proc. Natl. Acad. Sci. U. S. A. 2002;99:745&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC117376</ArticleId><ArticleId IdType="pubmed">11805328</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman C.A., Monteiro M.J. The specificity of ubiquitin binding to ubiquilin-1 is regulated by sequences besides its UBA domain. Biochim. Biophys. Acta Gen. Subj. 2019;1863:1568&#x2013;1574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6679980</ArticleId><ArticleId IdType="pubmed">31175912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R., Aillet F., Lopitz-Otsoa F., Lang V., England P., Rodriguez M.S. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 2009;10:1250&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2775171</ArticleId><ArticleId IdType="pubmed">19798103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko H.S., Uehara T., Tsuruma K., Nomura Y. Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains. FEBS Lett. 2004;566:110&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">15147878</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims J.J., Haririnia A., Dickinson B.C., Fushman D., Cohen R.E. Avid interactions underlie the Lys63-linked polyubiquitin binding specificities observed for UBA domains. Nat. Struct. Mol. Biol. 2009;16:883&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2744598</ArticleId><ArticleId IdType="pubmed">19620964</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T.P., Kolaitis R.M., Kim H.J., O'Donovan K., Martyniak B., Colicino E., Hehnly H., Taylor J.P., Castaneda C.A. Ubiquitin modulates liquid-liquid phase separation of UBQLN2 via disruption of multivalent interactions. Mol. Cell. 2018;69:965&#x2013;978.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>Itakura E., Zavodszky E., Shao S., Wohlever M.L., Keenan R.J., Hegde R.S. Ubiquilins chaperone and triage mitochondrial membrane proteins for degradation. Mol. Cell. 2016;63:21&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4942676</ArticleId><ArticleId IdType="pubmed">27345149</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya H., Ohtake F., Arai N., Kaiho A., Yasuda S., Tanaka K., Saeki Y. In&#xa0;vivo ubiquitin linkage-type analysis reveals that the Cdc48-Rad23/Dsk2 Axis contributes to K48-linked chain specificity of the proteasome. Mol. Cell. 2017;66:488&#x2013;502.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28525741</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki R., Kawahara H. UBQLN4 recognizes mislocalized transmembrane domain proteins and targets these to proteasomal degradation. EMBO Rep. 2016;17:842&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5278606</ArticleId><ArticleId IdType="pubmed">27113755</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R., Bett J.S., Keuss M.J., Solovyova A., McWilliams T.G., Johnson C., Sahu I., Varghese J., Wood N., Wightman M., Osborne G., Bates G.P., Glickman M.H., Trost M., Knebel A. UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome. Cell. 2016;166:935&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteley A.M., Prado M.A., Peng I., Abbas A.R., Haley B., Paulo J.A., Reichelt M., Katakam A., Sagolla M., Modrusan Z., Lee D.Y., Roose-Girma M., Kirkpatrick D.S., McKenzie B.S., Gygi S.P. Ubiquilin1 promotes antigen-receptor mediated proliferation by eliminating mislocalized mitochondrial proteins. Elife. 2017;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5608509</ArticleId><ArticleId IdType="pubmed">28933694</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin I. The ubiquilin gene family: evolutionary patterns and functional insights. BMC Evol. Biol. 2014;14:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230246</ArticleId><ArticleId IdType="pubmed">24674348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.Y., Arnott D., Brown E.J. Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery. EMBO Rep. 2013;14:373&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3615663</ArticleId><ArticleId IdType="pubmed">23459205</ArticleId></ArticleIdList></Reference><Reference><Citation>N'Diaye E.N., Debnath J., Brown E.J. Ubiquilins accelerate autophagosome maturation and promote cell survival during nutrient starvation. Autophagy. 2009;5:573&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398896</ArticleId></ArticleIdList></Reference><Reference><Citation>N'Diaye E.N., Kajihara K.K., Hsieh I., Morisaki H., Debnath J., Brown E.J. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep. 2009;10:173&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2637314</ArticleId><ArticleId IdType="pubmed">19148225</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenberg C., Srinivasan D., Mah L., Kaushik S., Peterhoff C.M., Ugolino J., Fang S., Cuervo A.M., Nixon R.A., Monteiro M.J. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum. Mol. Genet. 2010;19:3219&#x2013;3232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2908472</ArticleId><ArticleId IdType="pubmed">20529957</ArticleId></ArticleIdList></Reference><Reference><Citation>Senturk M., Lin G., Zuo Z., Mao D., Watson E., Mikos A.G., Bellen H.J. Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat. Cell Biol. 2019;21:384&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6534127</ArticleId><ArticleId IdType="pubmed">30804504</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J.J., Cai A., Greenslade J.E., Higgins N.R., Fan C., Le N.T.T., Tatman M., Whiteley A.M., Prado M.A., Dieriks B.V., Curtis M.A., Shaw C.E., Siddique T., Faull R.L.M., Scotter E.L. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function. Proc. Natl. Acad. Sci. U. S. A. 2020;117:15230&#x2013;15241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334651</ArticleId><ArticleId IdType="pubmed">32513711</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilpin K.M., Chang L., Monteiro M.J. ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. Hum. Mol. Genet. 2015;24:2565&#x2013;2577.</Citation><ArticleIdList><ArticleId IdType="pubmed">25616961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Monteiro M.J. Defective proteasome delivery of polyubiquitinated proteins by ubiquilin-2 proteins containing ALS mutations. PLoS One. 2015;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468220</ArticleId><ArticleId IdType="pubmed">26075709</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander E.J., Ghanbari Niaki A., Zhang T., Sarkar J., Liu Y., Nirujogi R.S., Pandey A., Myong S., Wang J. Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. Proc. Natl. Acad. Sci. U. S. A. 2018;115:E11485&#x2013;E11494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6298105</ArticleId><ArticleId IdType="pubmed">30442662</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey L.M., Safren N., Pithadia A.S., Gerson J.E., Dulchavsky M., Fischer S., Patel R., Lantis G., Ashraf N., Kim J.H., Meliki A., Minakawa E.N., Barmada S.J., Ivanova M.I., Paulson H.L. Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly. Proc. Natl. Acad. Sci. U. S. A. 2018;115:E10495&#x2013;E10504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217421</ArticleId><ArticleId IdType="pubmed">30333186</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey L.M., Sandoval-Pistorius S.S., Moore S.J., Gerson J.E., Komlo R., Fischer S., Negron-Rios K.Y., Crowley E.V., Padron F., Patel R., Murphy G.G., Paulson H.L. Modeling UBQLN2-mediated neurodegenerative disease in mice: shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity. Neurobiol. Dis. 2020;143:105016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7504910</ArticleId><ArticleId IdType="pubmed">32653673</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., Jiang H., Hirano M., Rampersaud E., Jansen G.H., Donkervoort S. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerson J.E., Safren N., Fischer S., Patel R., Crowley E.V., Welday J.P., Windle A.K., Barmada S., Paulson H.L., Sharkey L.M. Ubiquilin-2 differentially regulates polyglutamine disease proteins. Hum. Mol. Genet. 2020;29:2596&#x2013;2610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471500</ArticleId><ArticleId IdType="pubmed">32681165</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Liu M., Huang C., Liu X., Huang B., Li N., Zhou H., Xia X.G. Pathogenic Ubqln2 gains toxic properties to induce neuron death. Acta Neuropathol. 2015;129:417&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777328</ArticleId><ArticleId IdType="pubmed">25388785</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E., Chartier L., Amador M.D., Lam R., Lautrette G., Nicol M., Machat S., Da Barroca S., Moigneu C., Mairey M., Larmonier T., Saker S., Dussert C., Forlani S., Fontaine B. Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis. Neurobiol. Aging. 2017;58:239.e11&#x2013;239.e20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28716533</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K.L., Warraich S.T., Yang S., Solski J.A., Fernando R., Rouleau G.A., Nicholson G.A., Blair I.P. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol. Aging. 2012;33:2527.e3&#x2013;2527.e10.</Citation><ArticleIdList><ArticleId IdType="pubmed">22717235</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H., Suhail H., Szuto A., Camu W., Salachas F., Meininger V., Bouchard J.P., Dupre N., Dion P.A., Rouleau G.A. UBQLN2 mutations are rare in French and French-Canadian amyotrophic lateral sclerosis. Neurobiol. Aging. 2012;33:2230.e1&#x2013;2230.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22560112</ArticleId></ArticleIdList></Reference><Reference><Citation>Synofzik M., Maetzler W., Grehl T., Prudlo J., Vom Hagen J.M., Haack T., Rebassoo P., Munz M., Schols L., Biskup S. Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype. Neurobiol. Aging. 2012;33:2949.e13&#x2013;2949.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">22892309</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford N.J., Lewis J., Clippinger A.K., Thomas M.A., Adamson J., Cruz P.E., Cannon A., Xu G., Golde T.E., Shaw G., Borchelt D.R., Giasson B.I. Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions. Brain Res. 2013;1524:62&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3914001</ArticleId><ArticleId IdType="pubmed">23774650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Lim P.J., Yin C., Rieckher M., Vogel B.E., Monteiro M.J. Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin. Hum. Mol. Genet. 2006;15:1025&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pubmed">16461334</ArticleId></ArticleIdList></Reference><Reference><Citation>El Ayadi A., Stieren E.S., Barral J.M., Boehning D. Ubiquilin-1 regulates amyloid precursor protein maturation and degradation by stimulating K63-linked polyubiquitination of lysine 688. Proc. Natl. Acad. Sci. U. S. A. 2012;109:13416&#x2013;13421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3421158</ArticleId><ArticleId IdType="pubmed">22847417</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah A.L., Perry G., Smith M.A., Monteiro M.J. Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J.&#xa0;Cell Biol. 2000;151:847&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169435</ArticleId><ArticleId IdType="pubmed">11076969</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford D.L., Monteiro M.J. Dimerization of ubiquilin is dependent upon the central region of the protein: evidence that the monomer, but not the dimer, is involved in binding presenilins. Biochem. J. 2006;399:397&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1615901</ArticleId><ArticleId IdType="pubmed">16813565</ArticleId></ArticleIdList></Reference><Reference><Citation>Le N.T., Chang L., Kovlyagina I., Georgiou P., Safren N., Braunstein K.E., Kvarta M.D., Van Dyke A.M., LeGates T.A., Philips T., Morrison B.M., Thompson S.M., Puche A.C., Gould T.D., Rothstein J.D. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proc. Natl. Acad. Sci. U. S. A. 2016;113:E7580&#x2013;E7589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127348</ArticleId><ArticleId IdType="pubmed">27834214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomash R.M., Gu X., Youle R.J., Lu W., Roche K.W. Neurolastin, a dynamin family GTPase, regulates excitatory synapses and spine density. Cell Rep. 2015;12:743&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4567839</ArticleId><ArticleId IdType="pubmed">26212327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T., Okumura F., Kano S., Kondo T., Ariga T., Hatakeyama S. TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription. J.&#xa0;Cell Sci. 2011;124(Pt 20):3492&#x2013;3502.</Citation><ArticleIdList><ArticleId IdType="pubmed">21984809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang A.P., Beck J.S., Yen H.J., Tayeh M.K., Scheetz T.E., Swiderski R.E., Nishimura D.Y., Braun T.A., Kim K.Y., Huang J., Elbedour K., Carmi R., Slusarski D.C., Casavant T.L., Stone E.M. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11) Proc. Natl. Acad. Sci. U. S. A. 2006;103:6287&#x2013;6292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1458870</ArticleId><ArticleId IdType="pubmed">16606853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudryashova E., Kudryashov D., Kramerova I., Spencer M.J. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. J.&#xa0;Mol. Biol. 2005;354:413&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">16243356</ArticleId></ArticleIdList></Reference><Reference><Citation>Locke M., Tinsley C.L., Benson M.A., Blake D.J. TRIM32&#xa0;is an E3 ubiquitin ligase for dysbindin. Hum. Mol. Genet. 2009;18:2344&#x2013;2358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2694686</ArticleId><ArticleId IdType="pubmed">19349376</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S., Zhai B., Gygi S.P., Goldberg A.L. Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy. J.&#xa0;Cell Biol. 2012;198:575&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514026</ArticleId><ArticleId IdType="pubmed">22908310</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Hu M.M., Wang Y.Y., Shu H.B. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J.&#xa0;Biol. Chem. 2012;287:28646&#x2013;28655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3436586</ArticleId><ArticleId IdType="pubmed">22745133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.C., Huang W.C., Lin J.H., Kao T.J., Lin H.C., Lee K.H., Lin H.C., Shen C.J., Chang W.C., Huang C.C. Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology. J.&#xa0;Biomed. Sci. 2018;25:76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6223059</ArticleId><ArticleId IdType="pubmed">30404641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.C., Umanah G.K., Dephoure N., Andrabi S.A., Gygi S.P., Dawson T.M., Dawson V.L., Rutter J. Msp1/ATAD1 maintains mitochondrial function by facilitating the degradation of mislocalized tail-anchored proteins. EMBO J. 2014;33:1548&#x2013;1564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4198051</ArticleId><ArticleId IdType="pubmed">24843043</ArticleId></ArticleIdList></Reference><Reference><Citation>Okreglak V., Walter P. The conserved AAA-ATPase Msp1 confers organelle specificity to tail-anchored proteins. Proc. Natl. Acad. Sci. U. S. A. 2014;111:8019&#x2013;8024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4050615</ArticleId><ArticleId IdType="pubmed">24821790</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt J., Veith A.M., Volff J.N. A&#xa0;family of neofunctionalized Ty3/gypsy retrotransposon genes in mammalian genomes. Cytogenet. Genome Res. 2005;110:307&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">16093683</ArticleId></ArticleIdList></Reference><Reference><Citation>Lux A., Beil C., Majety M., Barron S., Gallione C.J., Kuhn H.-M., Berg J.N., Kioschis P., Marchuk D.A., Hafner M. Human retroviral gag - and gag-pol -like proteins interact with the transforming growth factor-&#x3b2; receptor activin receptor-like kinase 1. J. Biol. Chem. 2005;280:8482&#x2013;8493.</Citation><ArticleIdList><ArticleId IdType="pubmed">15611116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lux H., Flammann H., Hafner M., Lux A. Genetic and molecular analyses of PEG10 reveal new aspects of genomic organization, transcription and translation. PLoS ONE. 2010;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2800197</ArticleId><ArticleId IdType="pubmed">20084274</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark M.B., Janicke M., Gottesbuhren U., Kleffmann T., Legge M., Poole E.S., Tate W.P. Mammalian gene PEG10 expresses two reading frames by high efficiency -1 frameshifting in embryonic-associated tissues. J.&#xa0;Biol. Chem. 2007;282:37359&#x2013;37369.</Citation><ArticleIdList><ArticleId IdType="pubmed">17942406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigemoto K., Brennan J., Walls E., Watson C.J., Stott D., Rigby P.W., Reith A.D. Identification and characterisation of a developmentally regulated mammalian gene that utilises -1 programmed ribosomal frameshifting. Nucleic Acids Res. 2001;29:4079&#x2013;4088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC60235</ArticleId><ArticleId IdType="pubmed">11574691</ArticleId></ArticleIdList></Reference><Reference><Citation>Abed M., Verschueren E., Budayeva H., Liu P., Kirkpatrick D.S., Reja R., Kummerfeld S.K., Webster J.D., Gierke S., Reichelt M., Anderson K.R., Newman R.J., Roose-Girma M., Modrusan Z., Pektas H. The Gag protein PEG10 binds to RNA and regulates&#xa0;trophoblast stem cell lineage specification. PLoS One. 2019;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450627</ArticleId><ArticleId IdType="pubmed">30951545</ArticleId></ArticleIdList></Reference><Reference><Citation>Akamatsu S., Wyatt A.W., Lin D., Lysakowski S., Zhang F., Kim S., Tse C., Wang K., Mo F., Haegert A., Brahmbhatt S., Bell R., Adomat H., Kawai Y., Xue H. The placental gene PEG10 promotes progression of neuroendocrine prostate cancer. Cell Rep. 2015;12:922&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pubmed">26235627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono R., Nakamura K., Inoue K., Naruse M., Usami T., Wakisaka-Saito N., Hino T., Suzuki-Migishima R., Ogonuki N., Miki H., Kohda T., Ogura A., Yokoyama M., Kaneko-Ishino T., Ishino F. Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality. Nat. Genet. 2006;38:101&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">16341224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashley J., Cordy B., Lucia D., Fradkin L.G., Budnik V., Thomson T. Retrovirus-like gag protein Arc1 binds RNA and traffics across synaptic boutons. Cell. 2018;172:262&#x2013;274.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5793882</ArticleId><ArticleId IdType="pubmed">29328915</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastuzyn E.D., Day C.E., Kearns R.B., Kyrke-Smith M., Taibi A.V., McCormick J., Yoder N., Belnap D.M., Erlendsson S., Morado D.R., Briggs J.A.G., Feschotte C., Shepherd J.D. The neuronal gene arc encodes a repurposed retrotransposon gag protein that mediates intercellular RNA transfer. Cell. 2018;172:275&#x2013;278.e18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5884693</ArticleId><ArticleId IdType="pubmed">29328916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Pak C., Han Y., Ahlenius H., Zhang Z., Chanda S., Marro S., Patzke C., Acuna C., Covy J., Xu W., Yang N., Danko T., Chen L., Wernig M. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78:785&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3751803</ArticleId><ArticleId IdType="pubmed">23764284</ArticleId></ArticleIdList></Reference><Reference><Citation>N'Diaye E.N., Hanyaloglu A.C., Kajihara K.K., Puthenveedu M.A., Wu P., von Zastrow M., Brown E.J. The ubiquitin-like protein PLIC-2 is a negative regulator of G protein-coupled receptor endocytosis. Mol. Biol. Cell. 2008;19:1252&#x2013;1260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2262968</ArticleId><ArticleId IdType="pubmed">18199683</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaksonen M., Roux A. Mechanisms of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2018;19:313&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">29410531</ArticleId></ArticleIdList></Reference><Reference><Citation>Komander D., Rape M. The ubiquitin code. Annu. Rev. Biochem. 2012;81:203&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">22524316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauwers E., Jacob C., Andre B. K63-linked ubiquitin chains as a specific signal for protein sorting into the multivesicular body pathway. J.&#xa0;Cell Biol. 2009;185:493&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700384</ArticleId><ArticleId IdType="pubmed">19398763</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritsch J., Stephan M., Tchikov V., Winoto-Morbach S., Gubkina S., Kabelitz D., Schutze S. Cell fate decisions regulated by K63 ubiquitination of tumor necrosis factor receptor 1. Mol. Cell Biol. 2014;34:3214&#x2013;3228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4135562</ArticleId><ArticleId IdType="pubmed">24980434</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam S.S., Martell J.D., Kamer K.J., Deerinck T.J., Ellisman M.H., Mootha V.K., Ting A.Y. Directed evolution of APEX2&#xa0;for&#xa0;electron microscopy and proximity labeling. Nat. Methods. 2015;12:51&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4296904</ArticleId><ArticleId IdType="pubmed">25419960</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurlawala Z., Saurabh K., Dunaway R., Shah P.P., Siskind L.J., Beverly L.J. Ubiquilin proteins regulate EGFR levels and activity in lung adenocarcinoma cells. J.&#xa0;Cell Biochem. 2020;122:43&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">32720736</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Koppers M., Groen E.J.N., van den Heuvel D.M.A., Dini Modigliani S., Anink J.J., Fumoto K., van Diggelen F., Snelting A., Sodaar P., Verheijen B.M., Demmers J.A.A., Veldink J.H., Aronica E., Bozzoni I. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol. 2016;132:175&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4947123</ArticleId><ArticleId IdType="pubmed">27164932</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Lyon D., Junge A., Wyder S., Huerta-Cepas J., Simonovic M., Doncheva N.T., Morris J.H., Bork P., Jensen L.J., Mering C.V. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607&#x2013;D613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M.H.H., Dikic I. The Cbl interactome and its functions. Nat. Rev. Mol. Cell Biol. 2005;6:907&#x2013;918.</Citation><ArticleIdList><ArticleId IdType="pubmed">16227975</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigismund S., Algisi V., Nappo G., Conte A., Pascolutti R., Cuomo A., Bonaldi T., Argenzio E., Verhoef L.G., Maspero E., Bianchi F., Capuani F., Ciliberto A., Polo S., Di Fiore P.P. Threshold-controlled ubiquitination of the EGFR directs receptor fate. EMBO J. 2013;32:2140&#x2013;2157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3730230</ArticleId><ArticleId IdType="pubmed">23799367</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh L.K., Sorkin A. Endocytosis of receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol. 2013;5:a017459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3632065</ArticleId><ArticleId IdType="pubmed">23637288</ArticleId></ArticleIdList></Reference><Reference><Citation>Piper R.C., Dikic I., Lukacs G.L. Ubiquitin-dependent sorting in endocytosis. Cold Spring Harb. Perspect. Biol. 2014;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3941215</ArticleId><ArticleId IdType="pubmed">24384571</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietri M., Radulovic M., Stenmark H. The many functions of ESCRTs. Nat. Rev. Mol. Cell Biol. 2020;21:25&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">31705132</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritsch J., Zingler P., Sarchen V., Heck A.L., Schutze S. Role of ubiquitination and proteolysis in the regulation of pro- and anti-apoptotic TNF-R1 signaling. Biochim. Biophys. Acta Mol. Cell Res. 2017;1864(11 Pt B):2138&#x2013;2146.</Citation><ArticleIdList><ArticleId IdType="pubmed">28765050</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou F., Garcia de Vinuesa A., de Kruijf E.M., Mesker W.E., Hui L., Drabsch Y., Li Y., Bauer A., Rousseau A., Sheppard K.A., Mickanin C., Kuppen P.J., Lu C.X., Ten Dijke P. TRAF4 promotes TGF-beta receptor signaling and drives breast cancer metastasis. Mol. Cell. 2013;51:559&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pubmed">23973329</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaise S., Kneib M., Rousseau A., Gambino F., Chenard M.P., Messadeq N., Muckenstrum M., Alpy F., Tomasetto C., Humeau Y., Rio M.C. In&#xa0;vivo evidence that TRAF4 is required for central nervous system myelin homeostasis. PLoS One. 2012;7:e30917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281907</ArticleId><ArticleId IdType="pubmed">22363515</ArticleId></ArticleIdList></Reference><Reference><Citation>Maminska A., Bartosik A., Banach-Orlowska M., Pilecka I., Jastrzebski K., Zdzalik-Bielecka D., Castanon I., Poulain M., Neyen C., Wolinska-Niziol L., Torun A., Szymanska E., Kowalczyk A., Piwocka K., Simonsen A. ESCRT proteins restrict constitutive NF-kappaB signaling by trafficking cytokine receptors. Sci. Signal. 2016;9:ra8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26787452</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J.H., Sun S.C. Tumor necrosis factor receptor-associated factor regulation of nuclear factor kappaB and mitogen-activated protein kinase pathways. Front. Immunol. 2018;9:1849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6094638</ArticleId><ArticleId IdType="pubmed">30140268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J., Li Q., Mao A.P., Hu M.M., Shu H.B. TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination. J.&#xa0;Mol. Cell Biol. 2014;6:154&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">24755855</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher A.J., Vaysburd M., Maslen S., Zeng J., Skehel J.M., Towers G.J., James L.C. Trivalent RING assembly on retroviral capsids activates TRIM5 ubiquitination and innate immune signaling. Cell Host Microbe. 2018;24:761&#x2013;775.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6299210</ArticleId><ArticleId IdType="pubmed">30503508</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis M.E., Gack M.U. Ubiquitination in the antiviral immune response. Virology. 2015;479-480:52&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4774549</ArticleId><ArticleId IdType="pubmed">25753787</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Huang S., Wang X., Wen M., Zheng J., Wang W., Fu Y., Tian S., Li L., Li Z., Wang X. The otubain YOD1 suppresses aggregation and activation of the signaling adaptor MAVS through Lys63-linked deubiquitination. J.&#xa0;Immunol. 2019;202:2957&#x2013;2970.</Citation><ArticleIdList><ArticleId IdType="pubmed">30952814</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorkoy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., Stenmark H., Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J.&#xa0;Cell Biol. 2005;171:603&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2171557</ArticleId><ArticleId IdType="pubmed">16286508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkin V., Lamark T., Sou Y.S., Bjorkoy G., Nunn J.L., Bruun J.A., Shvets E., McEwan D.G., Clausen T.H., Wild P., Bilusic I., Theurillat J.P., Overvatn A., Ishii T., Elazar Z. A&#xa0;role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol. Cell. 2009;33:505&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">19250911</ArticleId></ArticleIdList></Reference><Reference><Citation>Grumati P., Dikic I. Ubiquitin signaling and autophagy. J.&#xa0;Biol. Chem. 2018;293:5404&#x2013;5413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5900779</ArticleId><ArticleId IdType="pubmed">29187595</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin E.J., Shin H.M., Nam E., Kim W.S., Kim J.H., Oh B.H., Yun Y. DeSUMOylating isopeptidase: a second class of SUMO protease. EMBO Rep. 2012;13:339&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3321169</ArticleId><ArticleId IdType="pubmed">22370726</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirayama S., Sugihara M., Morito D., Iemura S.I., Natsume T., Murata S., Nagata K. Nuclear export of ubiquitinated proteins via the UBIN-POST system. Proc. Natl. Acad. Sci. U. S. A. 2018;115:E4199&#x2013;E4208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939056</ArticleId><ArticleId IdType="pubmed">29666234</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttlin E.L., Bruckner R.J., Paulo J.A., Cannon J.R., Ting L., Baltier K., Colby G., Gebreab F., Gygi M.P., Parzen H., Szpyt J., Tam S., Zarraga G., Pontano-Vaites L., Swarup S. Architecture of the human interactome defines protein communities and disease networks. Nature. 2017;545:505&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5531611</ArticleId><ArticleId IdType="pubmed">28514442</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweppe D.K., Huttlin E.L., Harper J.W., Gygi S.P. BioPlex display: an interactive suite for large-scale AP-MS protein-protein interaction data. J.&#xa0;Proteome Res. 2018;17:722&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7029486</ArticleId><ArticleId IdType="pubmed">29054129</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose C.M., Isasa M., Ordureau A., Prado M.A., Beausoleil S.A., Jedrychowski M.P., Finley D.J., Harper J.W., Gygi S.P. Highly multiplexed quantitative mass spectrometry analysis of ubiquitylomes. Cell Syst. 2016;3:395&#x2013;403.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241079</ArticleId><ArticleId IdType="pubmed">27667366</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey L.K., Mah A.L., Ford D.L., Miller J., Liang J., Doong H., Monteiro M.J. Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins. J.&#xa0;Alzheimers Dis. 2004;6:79&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">15004330</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurskaya N.G., Verkhusha V.V., Shcheglov A.S., Staroverov D.B., Chepurnykh T.V., Fradkov A.F., Lukyanov S., Lukyanov K.A. Engineering of a monomeric green-to-red photoactivatable fluorescent protein induced by blue light. Nat. Biotechnol. 2006;24:461&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">16550175</ArticleId></ArticleIdList></Reference><Reference><Citation>Halloran M., Ragagnin A.M.G., Vidal M., Parakh S., Yang S., Heng B., Grima N., Shahheydari H., Soo K.Y., Blair I., Guillemin G.J., Sundaramoorthy V., Atkin J.D. Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress. Cell Mol. Life Sci. 2020;77:3859&#x2013;3873.</Citation><ArticleIdList><ArticleId IdType="pubmed">31802140</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue M., Takahashi K., Niide O., Shibata M., Fukuzawa M., Ra C. LDOC1, a novel MZF-1-interacting protein, induces apoptosis. FEBS Lett. 2005;579:604&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">15670815</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasaki K., Schem C., von Kaisenberg C., Biallek M., Rosel F., Jonat W., Maass N. Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int. J. Cancer. 2003;105:454&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">12712434</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota T., Mishra M., Akatsu H., Tani Y., Miyauchi T., Yamamoto T., Kosaka K., Nagai Y., Sawada T., Heese K. Brain site-specific gene expression analysis in Alzheimer's disease patients. Eur. J. Clin. Invest. 2006;36:820&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">17032350</ArticleId></ArticleIdList></Reference><Reference><Citation>Assereto S., Piccirillo R., Baratto S., Scudieri P., Fiorillo C., Massacesi M., Traverso M., Galietta L.J., Bruno C., Minetti C., Zara F., Gazzerro E. The ubiquitin ligase tripartite-motif-protein 32 is induced in Duchenne muscular dystrophy. Lab. Invest. 2016;96:862&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pubmed">27295345</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Wu W., Yang H., Zhou Z., Zhu X., Sun C., Liu Y., Yu Z., Chen Y., Wang Y. Upregulated expression of TRIM32 is involved in Schwann cell differentiation, migration and neurite outgrowth after sciatic nerve crush. Neurochem. Res. 2017;42:1084&#x2013;1095.</Citation><ArticleIdList><ArticleId IdType="pubmed">28025799</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren Y., Janssens J., Van Dam D., De Deyn P.P. Serotonergic dysfunction in amyotrophic lateral sclerosis and Parkinson's disease: similar mechanisms, dissimilar outcomes. Front. Neurosci. 2018;12:185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869258</ArticleId><ArticleId IdType="pubmed">29615862</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Gulbranson D.R., Hou Z., Bolin J.M., Ruotti V., Probasco M.D., Smuga-Otto K., Howden S.E., Diol N.R., Propson N.E., Wagner R., Lee G.O., Antosiewicz-Bourget J., Teng J.M., Thomson J.A. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods. 2011;8:424&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3084903</ArticleId><ArticleId IdType="pubmed">21478862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuris J.A., Thompson D.B., Shu Y., Guilinger J.P., Bessen J.L., Hu J.H., Maeder M.L., Joung J.K., Chen Z.Y., Liu D.R. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in&#xa0;vitro and in&#xa0;vivo. Nat. Biotechnol. 2015;33:73&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4289409</ArticleId><ArticleId IdType="pubmed">25357182</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyenet S.J., Furrer S.A., Damian V.M., Baughan T.D., La Spada A.R., Garden G.A. A&#xa0;simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J.&#xa0;Vis. Exp. 2010;39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3121238</ArticleId><ArticleId IdType="pubmed">20495529</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber M., Wu T., Hanson J.E., Alam N.M., Solanoy H., Ngu H., Lauffer B.E., Lin H.H., Dominguez S.L., Reeder J., Tom J., Steiner P., Foreman O., Prusky G.T., Scearce-Levie K. Cognitive deficits, changes in synaptic function, and brain pathology in a mouse model of normal aging(1,2,3) eNeuro. 2015;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4606159</ArticleId><ArticleId IdType="pubmed">26473169</ArticleId></ArticleIdList></Reference><Reference><Citation>Foldi C.J., Eyles D.W., McGrath J.J., Burne T.H. The effects of breeding protocol in C57BL/6J mice on adult offspring behaviour. PLoS One. 2011;6:e18152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063184</ArticleId><ArticleId IdType="pubmed">21448436</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlister G.C., Nusinow D.P., Jedrychowski M.P., Wuhr M., Huttlin E.L., Erickson B.K., Rad R., Haas W., Gygi S.P. MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal. Chem. 2014;86:7150&#x2013;7158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215866</ArticleId><ArticleId IdType="pubmed">24927332</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P. A&#xa0;tissue-specific atlas of mouse protein phosphorylation and expression. Cell. 2010;143:1174&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035969</ArticleId><ArticleId IdType="pubmed">21183079</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarrete-Perea J., Yu Q., Gygi S.P., Paulo J.A. Streamlined tandem mass tag (SL-TMT) protocol: an efficient strategy for quantitative (phospho)proteome profiling using tandem mass tag-synchronous precursor selection-MS3. J.&#xa0;Proteome Res. 2018;17:2226&#x2013;2236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5994137</ArticleId><ArticleId IdType="pubmed">29734811</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulo J.A., O'Connell J.D., Gygi S.P. A&#xa0;triple knockout (TKO) proteomics standard for diagnosing ion interference in isobaric labeling experiments. J.&#xa0;Am. Soc. Mass Spectrom. 2016;27:1620&#x2013;1625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018445</ArticleId><ArticleId IdType="pubmed">27400695</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G., Wang L.G., Han Y., He Q.Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pichon C.E., Dominguez S.L., Solanoy H., Ngu H., Lewin-Koh N., Chen M., Eastham-Anderson J., Watts R., Scearce-Levie K. EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS. PLoS One. 2013;8:e62342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637182</ArticleId><ArticleId IdType="pubmed">23638043</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallop D.Y., Meilandt W.J., Gogineni A., Easley-Neal C., Wu T., Jubb A.M., Yaylaoglu M., Shamloo M., Tessier-Lavigne M., Scearce-Levie K., Weimer R.M. A&#xa0;death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models. J.&#xa0;Neurosci. 2014;34:6425&#x2013;6437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6608138</ArticleId><ArticleId IdType="pubmed">24806669</ArticleId></ArticleIdList></Reference><Reference><Citation>Paek J., Kalocsay M., Staus D.P., Wingler L., Pascolutti R., Paulo J.A., Gygi S.P., Kruse A.C. Multidimensional tracking of GPCR signaling via peroxidase-catalyzed proximity labeling. Cell. 2017;169:338&#x2013;349.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5514552</ArticleId><ArticleId IdType="pubmed">28388415</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y., Csordas A., Bai J., Bernal-Llinares M., Hewapathirana S., Kundu D.J., Inuganti A., Griss J., Mayer G., Eisenacher M., Perez E., Uszkoreit J., Pfeuffer J., Sachsenberg T., Yilmaz S. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442&#x2013;D450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323896</ArticleId><ArticleId IdType="pubmed">30395289</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>